Transcriptome Analysis Identifies Novel Prognostic Genes in Osteosarcoma

Figure 3

Prognostic risk model performance on the validation set (GSE21257 cohort). (a) The association of the risk scores with the survival time and status and expression levels of five genes in the validation set (GSE21257). The samples were ranked by the risk scores. (b) Kaplan-Meier curves for patients in the high-risk and low-risk groups in the validation set stratified by risk scores.

(a)

(b)